PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.74%
Revenue decline while VET shows 2.74% growth. Joel Greenblatt would examine competitive position erosion.
-20.09%
Cost reduction while VET shows 5.80% growth. Joel Greenblatt would examine competitive advantage.
-14.35%
Gross profit decline while VET shows 1.38% growth. Joel Greenblatt would examine competitive position.
2.87%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-43.51%
Other expenses reduction while VET shows 136.23% growth. Joel Greenblatt would examine efficiency.
-36.15%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-26.11%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
9.06%
Similar D&A growth to VET's 9.11%. Walter Schloss would investigate industry patterns.
75.27%
EBITDA growth exceeding 1.5x VET's 8.44%. David Dodd would verify competitive advantages.
-75.64%
EBITDA margin decline while VET shows 5.55% growth. Joel Greenblatt would examine position.
1.92%
Operating income growth below 50% of VET's 8.10%. Michael Burry would check for structural issues.
22.40%
Operating margin growth exceeding 1.5x VET's 5.21%. David Dodd would verify competitive advantages.
20692.01%
Other expenses growth above 1.5x VET's 66.65%. Michael Burry would check for concerning trends.
614.28%
Pre-tax income growth exceeding 1.5x VET's 13.37%. David Dodd would verify competitive advantages.
757.85%
Pre-tax margin growth exceeding 1.5x VET's 10.34%. David Dodd would verify competitive advantages.
610.40%
Tax expense growth above 1.5x VET's 9.95%. Michael Burry would check for concerning trends.
790.82%
Net income growth exceeding 1.5x VET's 13.41%. David Dodd would verify competitive advantages.
969.87%
Net margin growth exceeding 1.5x VET's 10.39%. David Dodd would verify competitive advantages.
669.68%
EPS growth exceeding 1.5x VET's 7.41%. David Dodd would verify competitive advantages.
695.33%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
16.06%
Share count reduction below 50% of VET's 1.90%. Michael Burry would check for concerns.
13.32%
Diluted share reduction below 50% of VET's 2.86%. Michael Burry would check for concerns.